Marked activity of irinotecan and rapamycin combination toward colon cancer cells in vivo and in vitro is mediated through cooperative modulation of the mammalian target of rapamycin/hypoxia-inducible factor-1alpha axis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples